| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000245322.2 |
Tanespimycin |
Esophageal cancer |
0.048889002 |
Resistant |
| ENSG00000245322.2 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.040082577 |
Resistant |
| ENSG00000245322.2 |
Tanespimycin |
Brain lower grade glioma |
0.005477994 |
Resistant |